| URL | https://www.americanpharmaceuticalreview.com/1315- |
| Source | americanpharmaceuticalreview.com |
| Date Published | 09/10/2025 |
| Company/Division name | Biocon Limited |
| Parent company | Biocon Generics Inc |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 30 |
| Country(ies) from which reshored: | India |
| City reshored to: | Cranbury |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |